Noblett Karen

CIK 00017562401 companyIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001756240

Recent Transactions

39 trades

Exercise/Conversion
Axonics, Inc.
Performance-Based Restricted Stock Units
2024-01-31−6,500→ 0 total
Exercise/Conversion
Axonics, Inc.
Performance-Based Restricted Stock Units
2024-01-31−15,000→ 0 total
Sale
Axonics, Inc.
Common Stock
2024-01-31$67.74/sh−11,288→ 34,428 total
Exercise/Conversion
Axonics, Inc.
Common Stock
2024-01-31+27,500→ 45,716 total
Sale
Axonics, Inc.
Common Stock
2024-01-08$69.00/sh−15,999→ 18,216 total
Sale
Axonics, Inc.
Common Stock
2023-12-28$63.28/sh−7,051→ 34,215 total
Sale
Axonics, Inc.
Common Stock
2023-12-26$63.00/sh−949→ 41,266 total
Sale
Axonics, Inc.
Common Stock
2023-02-01$61.02/sh−795→ 42,215 total
Sale
Axonics, Inc.
Common Stock
2023-02-01$60.43/sh−136→ 43,010 total
Exercise/Conversion
Axonics, Inc.
Performance-Based Restricted Stock Units
2023-01-31−4,250→ 0 total
Exercise/Conversion
Axonics, Inc.
Common Stock
2023-01-31+10,250→ 46,849 total
Award
Axonics, Inc.
Common Stock
2023-01-31+5,000→ 36,599 total
Sale
Axonics, Inc.
Common Stock
2023-01-31$61.12/sh−1,536→ 43,146 total
Exercise/Conversion
Axonics, Inc.
Performance-Based Restricted Stock Units
2023-01-31−6,000→ 0 total
Award
Axonics, Inc.
Performance-Based Restricted Stock Units
2023-01-31+15,000→ 15,000 total
Award
Axonics, Inc.
Performance-Based Restricted Stock Units
2023-01-31+5,000→ 5,000 total
Sale
Axonics, Inc.
Common Stock
2023-01-31$61.17/sh−2,167→ 44,682 total
Sale
Axonics, Inc.
Common Stock
2022-09-12$78.16/sh−32,483→ 31,599 total
Exercise/Conversion
Axonics, Inc.
Stock Options (Right to buy)
2022-09-12−13,964→ 6,348 total
Exercise/Conversion
Axonics, Inc.
Common Stock
2022-09-12$14.19/sh+18,519→ 50,118 total
Exercise/Conversion
Axonics, Inc.
Common Stock
2022-09-12$25.82/sh+13,964→ 64,082 total
Exercise/Conversion
Axonics, Inc.
Stock Option (Right to Buy)
2022-09-12−18,519→ 2,963 total
Sale
Axonics, Inc.
Common Stock
2022-09-07$71.53/sh−10,454→ 31,599 total
Sale
Axonics, Inc.
Common Stock
2022-03-18$57.23/sh−13,531→ 42,053 total
Exercise/Conversion
Axonics, Inc.
Performance-Based Restricted Stock Units
2022-02-03−14,130→ 0 total
Exercise/Conversion
Axonics, Inc.
Performance-Based Restricted Stock Units
2022-02-03−5,333→ 0 total
Sale
Axonics, Inc.
Common Stock
2022-02-03$49.03/sh−339→ 55,584 total
Exercise/Conversion
Axonics, Inc.
Common Stock
2022-02-03+19,463→ 62,266 total
Sale
Axonics, Inc.
Common Stock
2022-02-03$48.21/sh−6,343→ 55,923 total
Award
Axonics, Inc.
Common Stock
2022-01-31+5,350→ 42,803 total
Award
Axonics, Inc.
Performance-Based Restricted Stock Units
2022-01-31+4,250→ 4,250 total
Award
Axonics, Inc.
Performance-Based Restricted Stock Units
2022-01-31+3,250→ 3,250 total
Exercise/Conversion
Axonics, Inc.
Common Stock
2019-07-23$1.63/sh+6,002→ 54,124 total
Exercise/Conversion
Axonics, Inc.
Common Stock
2019-07-23$0.98/sh+8,402→ 48,122 total
Exercise/Conversion
Axonics, Inc.
Stock Option (Right to Buy)
2019-07-23−6,002→ 11,998 total
Exercise/Conversion
Axonics, Inc.
Stock Option (Right to Buy)
2019-07-23−8,402→ 1,198 total
Award
Axonics, Inc.
Performance-Based Restricted Stock Units
2019-01-30+2,667→ 2,667 total
Award
Axonics, Inc.
Stock Option (Right to Buy)
2019-01-30+35,555→ 35,555 total
Award
Axonics, Inc.
Performance-Based Restricted Stock Units
2019-01-30+2,667→ 2,667 total

Companies

Axonics, Inc.
Chief Medical Officer

Recent Filings

Address

26 TECHNOLOGY DRIVE

IRVINE, CA, 92618

View on SEC.gov